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Purpose: The purpose of this study is to link both numeric and structural chromosomal 
aberrations to the effectiveness of radiotherapy in chemotherapy refractory tumor cells.
Materials and methods: Neuroblastoma (LAN-1) and 79HF6 glioblastoma cells derived 
from patients and their chemoresistant sublines were artificially cultured as neurospheres 
and irradiated by X-rays and heavy ions sources. All the cell lines were irradiated by 
Carbon-SIS with LET of 100  keV/μm. However, 79HF6 cells and LAN-1 cells were 
also irradiated by Carbon-UNILAC with LET of 168 keV/μm and Nickel ions with LET 
of 174 keV/μm, respectively. The effect of radiation on the survival and proliferation of 
cells was addressed by standard clonogenic assays. In order to analyze cell karyotype 
standard Giemsa staining, multicolor fluorescence in  situ hybridization (mFISH) and 
multicolor banding (mBAND) techniques were applied.
results: Relative biological effectiveness values of heavy ion beams relative to X-rays 
at the D10 values were found between 2.3 and 2.6 with Carbon-SIS and Nickel for 
LAN-1 and between 2.5 and 3.4 with Carbon-SIS and Carbon-UNILAC for 79HF6 cells. 
Chemorefractory LAN-1RETO cells were found more radioresistant than untreated LAN-
1WT cells. 79HF6RETO glioblastoma cells were found more radiosensitive than cytostatic 
sensitive cells 79HF6WT. Sphere formation assay showed that LAN-1RETO cells were able 
to form spheres in serum-free culture, whereas 79HF6 cells could not. Most of 79HF6WT 
cells revealed a number of 71–90 chromosomes, whereas 79HF6RETO revealed a number 
of 52–83 chromosomes. The majority of LAN-1WT cells revealed a number of 40–44 
chromosomes. mFISH analysis showed some stable aberrations, especially on chromo-
some 10 as judged by the impossibility to label this region with specific probes. This was 
corroborated using mBAND analysis.
conclusion: Heavy ion irradiation was more effective than X-ray in both cytostatic naive 
cancer and chemoresistant cell lines. LAN-1RETO chemoresistant neuroblastoma cells 
were found to be more radioresistant than the cytostatic naive cells (LAN-1WT), whereas 
this effect was not found in 79HF6 cells.
Keywords: chemoresistance, X-ray and heavy ion irradiation, relative biological effectiveness, neuroblastoma, 
glioblastoma
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inTrODUcTiOn
There is convincing evidence that many solid and hematological 
malignancies are organized hierarchically and contain a small 
population of cancer stem cells (CSCs) that possess the capacity 
to self-renew and to cause the heterogeneous lineages of cells 
that form the tumor (1). Consequently, cell heterogeneity of 
tumors may play an important role in tumor persistence and 
metastasis formation. Additionally, there is growing evidence 
that CSCs are inherently resistant to radiation and perhaps other 
conventional anticancer treatments, i.e., chemotherapy (2–4). 
These intrinsic mechanisms of resistance are responsible for a 
significant number of tumor recurrences (2, 3). Consequently, 
an effective anticancer treatment can only be achieved if this 
population is eliminated.
Chemotherapy has the advantage over radiotherapy in fight-
ing the disseminated metastatic situation but at higher costs 
for the organism as a whole. Contrary to that, radiotherapy is 
a more localized treatment, but it is less applicable once the 
cancer has spread to several regions. Contemporaneous studies 
have consistently shown that CSC phenotypes are triggered after 
chemotherapy courses with an accompanied radioresistance of 
cancer cells both in  vitro and in  vivo probably by preferential 
activation of the DNA damage response (5). This indicates the 
urgent necessity for reevaluation of conventional therapies and 
searching for new ones that focus on CSCs to enhance the efficacy 
of cancer treatments.
Neuroblastoma is one of the most common extracranial pedi-
atric tumors with a wide spectrum of clinical forms. The long-term 
survival of children with a high-risk clinical phenotype is <40% 
(especially those with MYCN amplification) (6). Glioblastoma is 
the most aggressive brain tumor in adults. In spite of multimodal 
therapy, the median survival is only around 14 months with early 
recurrences (and infiltrative events) in the brain (7). The exist-
ence (and local spread) of CSCs may be an important reason for 
the treatment failure due to its resistance to conventional therapy, 
which leads to a poor prognosis.
Culturing cancer cells in the presence of a low dose of 
chemotherapeutic agents is one of the approaches to enrich 
subpopulations with CSC-like phenotypes and related physiol-
ogy. Etoposide is a topoisomerase inhibitor and causes DNA 
breaks enforcing apoptosis in dividing cancer cells. It is used as 
a standard chemotherapy in many tumors, such as neuroblas-
toma. However, etoposide is also known as an inducing agent of 
multidrug-resistant cancer phenotypes. In this study, low dose of 
etoposide was used to enrich CSCs fraction in glioblastoma and 
neuroblastoma cell lines.
Particle radiotherapy is becoming more widely used because 
proton and heavy ions have a favorable depth–dose distribution 
and a higher relative biological effectiveness (RBE) compared 
with photon. Once cancer cells are exposed to this therapy, they 
suffer a complex and clustered DNA damage, which is unable to 
be repaired by cellular mechanisms independent of the reactive 
oxygen species formed after exposing cells to charged particles. 
Consequently, malignant cells are less radioresistance because 
the mechanisms responsible for DNA reparation work less 
effective (8).
Our works aimed at studying the survival of chemoresistant 
cells compared with their wild-type parentals after being exposed 
to X-rays and heavy ions. We also addressed the question if the 
karyotype and chromosomal number deviations are related to the 
survival.
MaTerials anD MeThODs
cell lines and culture conditions
Two parental and their subtypes highly chemotherapy refractory 
cell lines LAN-1WT, LAN-1RETO neuroblastoma and 79HF6WT, 
79HF6RETO glioblastoma multiforme derived from human tumors 
were used in this investigation. The LAN-1 cells were isolated from 
a bone marrow metastasis of a 2-year-old boy with neuroblas-
toma (clinical Stage IV), and the 79HF6 cells were isolated from 
a female adult patient. The etoposide-resistant sublines usyed in 
this work exhibit CSC features among a set of CSC markers, broad 
spectrum of cross-resistance to several cytostatics, and radiore-
sistance. The phenotype characteristics and the CSC features 
were published previously (5). Cells were cultured in Dulbecco’s 
modified Eagle medium (DMEM), supplemented with 10% fetal 
calf serum (FCS) and 1% penicillin/streptomycin (all purchased 
from Biochrom AG, Berlin, Germany), and kept in a humidified 
atmosphere of 5% CO2 at 37°C. Resistant to ETOposide (RETO) 
cells were constantly cultured in the medium containing 4 μg/
ml etoposide (Teva, Germany). The cell doubling time (tD) was 
determined in the exponential phase of the growth with the GSI 
in house program gd (©M. Krämer, 2003).
clonogenic assay
Clonogenic assay was performed to determine both clonogenic 
behavior and cell survival rates after irradiation. Cells were seeded 
in T25 flask containing around 100 viable colonies after irradia-
tion. LAN-1WT and LAN-1RETO cells were incubated for 9 days. 
79HF6WT cells were incubated for 11  days, whereas 79HF6RETO 
cells were incubated for 25 days. Colonies were fixed and stained 
with methylene blue. Colonies containing more than 50 cells were 
defined as survivors.
sphere Formation assay
Cells were cultured in serum-free neurobasal A medium (Gibco, 
Life Technologies, Germany) supplemented with B27 (Gibco, 
Life Technologies, Germany), 10 ng/ml human fibroblast growth 
factor-basic (Biochrom, Germany), 20 ng/ml human epidermal 
growth factor (Biochrom, Germany), and 0.1% bovine serum 
albumin fraction V (Roche Diagnostics, Germany) to observe 
the formation of neurospheres (9).
Karyotyping
For chromosome preparations, cells were seeded 48  h in T75 
culture flasks with 10 ml medium before the experiment in order 
to allow stabile attachment. One hundred microliters of colcemid 
(Roche Deutschland Holding GmbH, Germany) with the con-
centration of 10 μg/ml were added to the cultures. After 3.5  h 
of incubation for LAN-1 and 79HF6WT and 4 h for 79HF6RETO, 
cells were trypsinized and harvested. Cell suspension was 
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pelleted and carefully treated with prewarmed (37°C) 0.075M 
potassium chloride solution for 8  min and then fixed with 3:1 
ratio of MeOH:glacial acetic acid for 30 min at room temperature. 
After washing, cells were resuspended in proper volume of the 
mentioned fixative and dropped on wet slides. The slides were 
then air-dried for 24 h. The slides were stained with 5% Giemsa 
(Merck, Germany) solution for 10  min, washed with distilled 
water, and dried overnight.
Multicolor Fluorescence In Situ 
hybridization Technique and Multicolor 
Banding Technique
For multicolor fluorescence in  situ hybridization (mFISH) 
analysis, the slides were hybridized using the 24XCyte mFISH kit 
(Metasystems, Altlussheim, Germany) according to the protocol 
recommended by the manufacturer. In brief, the slides were 
first subjected to a denaturation followed by dehydration. An 
appropriate volume of DNA denatured probe was incubated in 
a humidified chamber at 37°C in the dark for 2 days. Afterward, 
the remaining hybridization probe was washed off. Finally, all 
DNA material was counterstained using DAPI/antifade (250 ng/
ml), and the slide was covered. The chromosomal dispersal 
was analyzed using fluorescence microscopy Imager Z1 (Zeiss, 
Germany). Probes labeled with FITC, Orange, Texas Red®, 
Aqua, CyTM5 (Cy5), and 4′,6-diamidino-2-phenylindol (DAPI) 
fluorochromes were used to visualize chromosomal segments. 
Karyotypes were (re)constructed using the Isis/mFISH software 
(Metasystems). The procedure of multicolor banding (mBAND) 
is similar to that of mFISH, performed with the mBAND kit 
(Metasystems, Altlussheim, Germany), as previously described.
ionizing irradiation
All the irradiations were performed in GSI. The X-ray irradiation 
was carried out using an Isovolt DS1 X-ray machine (Seifert, 
Ahrensberg, Germany), exposing cells to 250 kVp and 16 mA.
Ion irradiation was performed in a synchrotron machine of 
the GSI. For irradiation at Carbon-SIS facility, cells were cultured 
in T12.5 culture flasks and were completely filled with culture 
medium before irradiation. The cells were irradiated with 10 mm 
spread out Bragg peak (SOBP) with LET of 100 keV/μm. All the 
cell lines were irradiated by Carbon-SIS. For experiments using a 
Carbon-UNILAC, 79HF6 cells were cultured in 3 cm Petri dishes 
and placed into compatible Petri dish magazines for irradiation. 
The carbon ions had a primary energy of 11.4  MeV/u and the 
energy decreased to 9.9  MeV/u when stopping on target with 
the corresponding LET of 168  keV/μm (10). After irradiation, 
the inner border of Petri dish was cleaned using sterile cotton to 
remove unirradiated medium accumulated at the bottom of the 
inner border, because dishes were irradiated in a vertical posi-
tion. As survival of cells is related to the LET of the beam, we use 
those two carbon beams with different LETs. LAN-1 cells were 
also irradiated by Nickel ions with energy of 1 GeV/u and LET 
of 174 keV/μm, because the beam time is limited in GSI and we 
got the chance of irradiated by Nickel ions with similar LET to 
Carbon-UNILAC, which is a higher LET beam compared with 
Carbon-SIS.
Samples in triplicate were subjected to irradiation sections for 
each dose with X-ray, heavy ions, and repeated at least three times. 
The irradiation doses for LAN-1WT were fixed from 0 to 7 Gy for 
X-ray, from 0 to 2 Gy for Carbon, and from 0 to 2 Gy for Nickel. 
However, the doses for LAN-1RETO were from 0 to 9 Gy for X-ray, 
0 to 3.2 Gy for Carbon, and 0 to 2 Gy for Nickel. The doses for 
79HF6WT and 79HF6RETO were applied from 0 to 10 Gy for X-ray, 
0 to 5 Gy for Carbon-SIS, and 0 to 2.72 Gy for Carbon-Unilac.
Cell survival curves of X-ray were fitted with the linear-
quadratic model (Eq. 1):
 S e=
− −( )α βD D2  (1)
Cell survival curves of heavy ions were fitted with a pure 
exponential equation (Eq. 2):
 S e=
−( )αD  (2)
RBE10 values were calculated at 10% of survival level according 
to Eq. 3:
 RBE D  X ray D  ions1 1 10 0 0= - /  (3)
All of the fitting was performed with the GSI in house program 
gd (©M. Krämer, 2003).
statistical analysis
Experiments were performed at least in triplicate, and the survival 
fraction of cells was given as mean ± SD. Karyotype and mBAND 
figures were descriptive and therefore not statistically analyzed.
resUlTs
Differential growth Patterns of lan-1 
neuroblastoma and glioblastoma 79hF6 
cell lines
All four cell lines, both wild type and resistant, grew adherently. 
The growth kinetic for all cells shows differential pattern as 
jugged by their doubling times. In this regard, the replication of 
LAN-1WT, LAN-1RETO, 79HF6WT, and 79HF6RETO was observed at 
21.7 ± 0.7, 16.9 ± 0.8, 21.6 ± 0.3, and 56.7 ± 5.2 h, respectively. 
LAN-1WT could form spheres when cultured in serum-free 
neurobasal A medium, whereas the other tumor cells lines were 
not able to form neurospheres once cultured under this condition 
(Figure 1). LAN-1RETO and 79HF6RETO chemotherapy refractory 
cells are able to stably grow in the medium containing low 
concentrations of etoposide. The growth kinetic of LAN-1RETO 
cells showed a faster cell replication than the wild-type parentals. 
Contrary to that, 79HF6RETO cells grew slower than 79HF6WT. 
These dissimilar growth patterns are in part a consequence of the 
development of chemoresistance of both tumor entities, which 
are biochemically dissimilar.
effectiveness of heavy ion irradiation in 
comparison to X-ray
As previously published by our group and others, resistance to 
etoposide induces radioresistance in both LAN-1 neuroblastoma 
FigUre 1 | neurosphere-forming cells. LAN-1WT/RETO neuroblastoma cells and 79HF6WT/RETO glioblastoma cells have shown different morphology in serum-free 
neurobasal A medium. Resistant LAN-1 subline showed the capacity to form neurospheres, whereas their wild-type parental cells are not able to form spheres. 
79HF6WT/RETO cells did not alter their growth pattern once incubated in this defined condition. Magnification: LAN-1, 10×; 79HF6WT, 10×; 79HF6RETO, 10×; central 
picture, 20×. Pictures are representative for different experiments.
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and glioblastoma 79HF6 cell lines (5). To explore how heavy ion 
irradiation has advantages over the conventional X-ray exposures, 
we monitored the cell survival of these cells exposure to Carbon 
and Nickel ion irradiation.
The survival curves showed that heavy ion irradiation was 
more effective than X-ray in all four cell lines (Figures 2 and 3). 
The RBE values of heavy ions beam relative to X-rays at the D10 
values were from 2.3 to 2.6 for LAN-1 cells and 2.5 to 3.4 for 
79HF6 cells (Table 1). For LAN-1 cells, the etoposide-resistant 
subtypes (cultured in the presence of etoposide) were found to be 
more radioresistant than WT cells (cultured without etoposide) 
after X-ray and heavy ion irradiation (Figure 2), but for 79HF6 
cells, RETO cells are more sensitive than WT cells after X-ray and 
heavy ion irradiation (Figure 3).
chromosomal aberrations Found in lan-1 
neuroblastoma and glioblastoma 79hF6 
cell lines
In order to search for the cause of radioresistance, we analyzed 
the karyotype of all cells used in our study. Most of LAN− cells 
had 40–44 chromosomes, and mFISH showed some stable 
FigUre 3 | survival of 79hF6 glioblastoma cells after ionizing 
irradiation. 79HF6WT/RETO cells were irradiated with X-ray, Carbon-SIS 
(100 keV/μm), and Carbon-Unilac (168 keV/μm). Graphic depicts the results 
of three independent experiments. Points, the mean survival fractions;  
bars, SD.
FigUre 2 | survival of lan-1 neuroblastoma cells after ionizing 
irradiation. LAN-1WT/RETO cells were irradiated with X-ray, Nickel 
(174 keV/μm), and Carbon-SIS (100 keV/μm). Graphic depicts the results of 
three independent experiments. Points, the mean survival fractions; bars, SD.
TaBle 1 | relative biological effectiveness values of heavy ions in lan-1 neuroblastoma and 79hF6 glioblastoma cells.
cell line carbon carbon-sis carbon-Unilac nickel
LAN-1WT 2.60 ± 0.20 – – 2.30 ± 0.20
LAN-1RETO 2.28 ± 0.09 – – 2.42 ± 0.04
79HF6WT – 2.50 ± 0.10 2.90 ± 0.20 –
79HF6RETO – 2.70 ± 0.50 3.40 ± 0.20 –
The relative biological effectiveness (RBE) values of heavy ions beam relative to X-rays at the D10 values were found between 2.3 and 2.6 for LAN-1 and 2.5 and 3.4 for 79HF6 cells, 
respectively.
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The chromosomal number in 79HF6 glioblastoma cells enor-
mously differed in the resistant subline. Most of the 79HF6WT cells 
revealed a number of 71–90 chromosomes, whereas 79HF6WT 
cells reflected 52–83 chromosomes. The chromosomal number of 
79HF6RETO revealed two peaks (Figure 6). It indicated that when 
cells were exposed to etoposide, the chromosome had the ten-
dency to decrease to its relative normal ploidy. This phenomenon 
could be explained as the effort of tumor cells on maintaining 
gene stability. Diploid chromosomal distribution is more stable 
compared with polyploidy numbers, especially when tumor cells 
suffer the injury of chemical agents or other stressors. Tumors 
cells carrying a polyploidy derived a subgroup with a more stable 
karyotype in order to maintain the gene stability.
DiscUssiOn
Cancer stem cells show continuous self-renewal, extensive 
parenchymal migration/infiltration, and potential for full or 
partial differentiation in all cell types, which constitute a tumor. 
To explore how LAN-1 neuroblastoma and glioblastoma 79HF6 
cell lines growth, we cultured these cells under optimal condi-
tions for propagation in serum-free neurobasal A medium. It 
is known that under these conditions, cells displayed profound 
biological differences in growth patterns and were enforced to 
grow as non-adherent, multicellular spheres, inducing CSC-like 
populations (9).
Every cell type obviously showed different morphologies, as 
they were cultured in serum-free medium or serum-contained 
medium. Sphere formation assay (11, 12) performed to select 
CSC phenotypes from both cell types revealed that LAN-1RETO 
cells were able to form neurospheres after culturing them in 
serum-free medium, instead LAN-1WT, 79HF6WT, and 79HF6RETO 
cells were not capable to form neurospheres under the same con-
ditions. CSCs may have the competence of durable self-renew, the 
capacity to develop and maintain tumor-related cell heterogene-
ity, differentiation, as well as the ability of both radioresistance 
and chemoresistance. To confirm the existence of CSC features, 
cells were transplanted to hosts and expected to induce tumor 
and maintain the features of parental tumor cells (13, 14). Studies 
in the past (5) have shown that both cell lines have CSC-like 
features, including chemoresistance and radioresistance to X-ray.
Our studies revealed that heavy ions had higher cell killing 
efficiency in both neuroblastoma and glioblastoma cell lines, 
despite its chemoresistance and chromosomal normality status. 
79HF6WT cells were very resistant to X-ray. The survival rates of 
these cells were nearly not affected with 1 or 2 Gy of exposure to 
X-ray and were still around 5% with 10 Gy. This could explain why 
aberrations, especially on chromosome 10 with an unstained 
region (Figure  4), and mBAND showed the unstained region 
located on 10p (Figure 5).
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FigUre 4 | Karyotype of lan-1 neuroblastoma cells analyzed by mFish. LAN-1 cells revealed a range of 40–44 chromosomes per cell. Besides the 
segmental exchange between chromosomes, the most prominent observation in this cell line was an unstained region in chromosome 10. Structurally, chromosome 
10 appeared to be intact (lower picture) once stained with Giemsa, but lower arms were not able to hybridize with the corresponding probes. Picture is 
representative for several cells analyzed under the same conditions. Magnification 100×.
FigUre 5 | mBanD analysis of chromosome 10 of lan-1 
neuroblastoma cells. As detected in the karyotype, LAN-1 cells showed an 
unstained region that was localized on 10p. This arm was not able to 
hybridize with the corresponding probes directed toward this region. Picture 
is representative for several cells analyzed under the same conditions. 
Magnification 100×.
glioblastoma is so hard to be treated in clinic with conventional 
X-ray. However, RBE10 was 2.5–2.9, which indicates that heavy 
ions had notable advantages in killing radioresistant tumors as 
glioblastoma.
Our studies also revealed that LAN-1RETO cells were found 
more radioresistant to X-ray than LAN-1WT. Contrary to that, 
79HF6RETO glioblastoma cells were less radioresistant than its 
wild-type parentals. The probable reason for this difference 
could be the different growth rates or the chromosomal number 
(15, 16). 79HF6RETO revealed a high variation in number of 
chromosomes in comparison to the wild-type cells that are more 
homogeneous. Thus, cells with a chromosomal abnormality in 
number are more sensible to ion irradiation. Although LAN-
1RETO cells were made more resistant to radiation and were able 
to form neurospheres after exposure to etoposide, the opposite 
was true for 79HF6RETO. This may imply the higher level point 
that general CSC features are enhanced by etoposide in LAN-1 
and CSC features may be reduced by etoposide in 79HF6. This 
difference could be caused by the inherent biological difference 
of neuroblastoma and glioblastoma. It may also be related to the 
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FigUre 6 | studies on chromosome number in 79hF6 glioblastoma cells. 79HF6WT/RETO glioblastoma cells revealed strong differences in their chromosome 
number. Wild-type cells showed polyploidy (a). On the contrary, the resistant subline 79HF6RETO showed less numerical aberrations (B). Both diagrams were merged 
to provide an overall look of the chromosomal dispersion in both cells types (c). These differences were found to be highly significant once applied a descriptive 
statistic. Graphics are representative for several experiments with the same experimental conditions.
concentration of etoposide. When the concentration is different, 
the results could change. Clearly, more work is needed to find 
the reason.
The biological hallmark of neuroblastomas is the com-
plexity of the genetic abnormalities developed by the tumor 
cells, which are powerful prognostic markers. The most 
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segments are shorter than the probes of mFISH and mBAND, 
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aUThOr cOnTriBUTiOns
ZY: substantial contributions to the conception of the work, per-
forming the experiments, analysis, and interpretation of data for 
the work and drafting the work. CH: substantial contributions to 
the conception of the work, performing the experiments, analy-
sis. DP: substantial contributions to performing the experiments, 
analysis. WK-W: substantial contributions to the conception of 
the work, revising it critically for important intellectual content. 
G-LJ: substantial contributions to the conception of the work, 
revising it critically for important intellectual content. DD-C: 
substantial contributions to the conception of the work, revising 
it critically for important intellectual content. MD: substantial 
contributions to the conception of the work, revising it critically 
for important intellectual content.
9Yu et al. Radiation on Chemoresistant Tumor Cells
Frontiers in Oncology | www.frontiersin.org March 2016 | Volume 6 | Article 64
18. Altura RA, Maris JM, Li H, Boyett JM, Brodeur GM, Look AT. Novel 
regions of chromosomal loss in familial neuroblastoma by comparative 
genomic hybridization. Genes Chromosomes Cancer (1997) 19(3):176–84. 
doi:10.1002/(SICI)1098-2264(199707)19:3<176::AID-GCC7>3.0. 
CO;2-V 
19. Mora J, Cheung NK, Oplanich S, Chen L, Gerald WL. Novel regions of allelic 
imbalance identified by genome-wide analysis of neuroblastoma. Cancer Res 
(2002) 62(6):1761–7. 
20. Wee KB, Aguda BD. Akt versus p53 in a network of oncogenes and tumor 
suppressor genes regulating cell survival and death. Biophys J (2006) 
91(3):857–65. doi:10.1529/biophysj.105.077693 
21. Tarunina M, Alger L, Chu G, Munger K, Gudkov A, Jat PS. Functional 
genetic screen for genes involved in senescence: role of Tid1, a homo-
logue of the Drosophila tumor suppressor l(2)tid, in senescence and 
cell survival. Mol Cell Biol (2004) 24(24):10792–801. doi:10.1128/
MCB.24.24.10792-10801.2004 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2016 Yu, Hartel, Pignalosa, Kraft-Weyrather, Jiang, Diaz-Carballo and 
Durante. This is an open-access article distributed under the terms of the Creative 
Commons Attribution License (CC BY). The use, distribution or reproduction in 
other forums is permitted, provided the original author(s) or licensor are credited 
and that the original publication in this journal is cited, in accordance with accepted 
academic practice. No use, distribution or reproduction is permitted which does not 
comply with these terms.
